Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Placebo Controlled Clinical Trial of Efficacy of MYOcardial Protection in Patients With Postacute inFLAMmatory Cardiac involvEment Due to COVID-19

NCT05619653 is registered in ClinicalTrials.gov with Valentina Puentmann as lead sponsor.

NCT NCT05619653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05619653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Placebo Controlled Clinical Trial of Efficacy of MYOcardial Protection in Patients With Postacute inFLAMmatory Cardiac involvEment Due to COVID-19
Lead sponsor
Valentina Puentmann
Phase
Phase 3
Overall status
Active, not recruiting
Start date
December 12, 2022
Completion date
March 31, 2026
Enrollment
279 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 associated cardiac involvement, exercise intolerance, left ventricular dysfunction, long covid, microvascular angina, myocarditis, pericarditis, remodeling, left ventricle, remodeling, vascular, vascular inflammation